KalVista Pharmaceuticals (KALV) Total Debt (2014 - 2016)

KalVista Pharmaceuticals (KALV) has 3 years of Total Debt data on file, last reported at $4.7 million in Q1 2016.

• For the quarter ending Q1 2016, Total Debt rose 3.84% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2016 stood at $4.7 million (up 3.84% YoY), and the FY2016 full-year result was $127000.0, changed N/A from the prior year.
• Total Debt improved to $4.7 million in Q1 2016, from $4.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $4.7 million in Q1 2016 to a low of $4.4 million in Q4 2014.
• A 3-year average of $4.5 million and a median of $4.5 million in 2015 frame the typical range for Total Debt.
• Across the five-year window, Total Debt advanced 3.92% in 2015 and climbed 3.84% in 2016, its largest moves.
• Tracing KALV's Total Debt over 3 years: stood at $4.4 million in 2014, then advanced by 3.92% to $4.6 million in 2015, then increased by 0.91% to $4.7 million in 2016.
• Business Quant data shows KALV's Total Debt at $4.7 million in Q1 2016, $4.6 million in Q4 2015, and $4.6 million in Q3 2015.